The FDA has approved an expanded indication for mometasone furoate inhalation powder (Asmanex Twisthaler), somatropin (recombinant) injection (Accretropin), and micafungin infusion (Mycamine). Medscape Medical News
Genetic mutations that are associated with familial Mediterranean fever may confer protection against asthma, results of a study published in the December issue of the Annals of Allergy, Asthma, and Immunology suggest. Reuters Health Information